Glucocorticoid-Like Activity of Escin: A New Mechanism for an Old Drug.


Journal

Drug design, development and therapy
ISSN: 1177-8881
Titre abrégé: Drug Des Devel Ther
Pays: New Zealand
ID NLM: 101475745

Informations de publication

Date de publication:
2021
Historique:
received: 17 12 2020
accepted: 05 02 2021
entrez: 4 3 2021
pubmed: 5 3 2021
medline: 7 10 2021
Statut: epublish

Résumé

Saponins are a group of compounds used in clinical practice in the management of several diseases. Escin is a natural mixture of triterpene saponins which mainly consist of several isoforms, in which the α- and β-escin are predominant. β-escin is the major active compound that exerts a therapeutic effect by relieving tissue edema, promoting venous drainage, and reducing inflammation. In this review, we describe the features of its glucocorticoid-like activity that could explain its clinical effects. Using PubMed, Embase Cochrane library and reference lists for articles published until October 01, 2020, we documented that escin is likely able to exert its anti-inflammatory and anti-edematous effects through a glucocorticoid-like activity, but without the development of glucocorticoid-like adverse drug reactions.

Identifiants

pubmed: 33658760
doi: 10.2147/DDDT.S297501
pii: 297501
pmc: PMC7917317
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Escin 6805-41-0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

699-704

Informations de copyright

© 2021 Gallelli et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Molecules. 2019 Dec 23;25(1):
pubmed: 31878082
Nat Clin Pract Rheumatol. 2008 Oct;4(10):525-33
pubmed: 18762788
Pharmacol Res. 2003 Jun;47(6):493-9
pubmed: 12742002
Cell Tissue Res. 2014 Mar;355(3):597-605
pubmed: 24352805
Food Chem. 2020 Jul 15;318:126474
pubmed: 32151922
Cell. 2010 Mar 19;140(6):833-44
pubmed: 20303874
Pharmacol Rep. 2009 Jul-Aug;61(4):697-704
pubmed: 19815952
Eur J Pharm Sci. 2011 Jan 18;42(1-2):73-80
pubmed: 21040784
J Clin Pharmacol. 2020 Oct;60(10):1367-1375
pubmed: 32484278
J Immunol. 2015 May 15;194(10):4940-50
pubmed: 25876761
Arzneimittelforschung. 1979;29(4):672-5
pubmed: 582766
Protoplasma. 2019 Nov;256(6):1463-1486
pubmed: 31297656
Eur J Pharmacol. 1998 Mar 12;345(1):89-95
pubmed: 9593599
Toxicol Mech Methods. 2014 Dec;24(8):560-6
pubmed: 25137224
Drug Des Devel Ther. 2019 Sep 27;13:3425-3437
pubmed: 31631970
J Biol Chem. 1997 Dec 5;272(49):30607-10
pubmed: 9388192
Mol Cell Biol. 2002 Nov;22(22):7929-41
pubmed: 12391160
Nutrients. 2019 Apr 24;11(4):
pubmed: 31022842
Cell Death Differ. 2001 Feb;8(2):201-3
pubmed: 11313722
Chin J Nat Med. 2018 Feb;16(2):105-112
pubmed: 29455725
Vasa. 1992;21(2):188-92
pubmed: 1621440
Microvasc Res. 2008 Nov;76(3):202-7
pubmed: 18657550
Nature. 1990 Nov 8;348(6297):166-8
pubmed: 2234079
Tsitologiia. 2014;56(1):36-47
pubmed: 25509142
Farmaco. 1999 Nov-Dec;54(11-12):728-32
pubmed: 10668171
J Leukoc Biol. 2002 Jan;71(1):9-15
pubmed: 11781376
Bioessays. 1997 Feb;19(2):153-60
pubmed: 9046245
Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S13-8
pubmed: 22018178
Exp Ther Med. 2012 Apr;3(4):735-739
pubmed: 22969961
Cochrane Database Syst Rev. 2012 Nov 14;11:CD003230
pubmed: 23152216
Exp Ther Med. 2013 Aug;6(2):419-422
pubmed: 24137201
Org Biomol Chem. 2014 Nov 28;12(44):8803-22
pubmed: 25295776
Mol Cell Endocrinol. 2013 Nov 5;380(1-2):32-40
pubmed: 23403055
Exp Ther Med. 2017 May;13(5):2161-2168
pubmed: 28565823
J Pharmacol Pharmacother. 2014 Jul;5(3):193-6
pubmed: 25210399
J Immunol. 2007 Sep 15;179(6):3851-8
pubmed: 17785822
Evid Based Complement Alternat Med. 2015;2015:503617
pubmed: 26199634
Fitoterapia. 2011 Sep;82(6):861-7
pubmed: 21596110
Immunity. 1997 Dec;7(6):803-12
pubmed: 9430225
Annu Rev Immunol. 1998;16:225-60
pubmed: 9597130
Phytomedicine. 2011 Feb 15;18(4):272-7
pubmed: 20850956
J Clin Pharmacol. 2020 Jul;60(7):815-825
pubmed: 32441805
Cytokine Growth Factor Rev. 2010 Aug;21(4):275-86
pubmed: 20456998
J Immunol. 2015 Jun 15;194(12):6057-67
pubmed: 25964494
J Cell Physiol. 2007 Feb;210(2):489-97
pubmed: 17044077
Nat Prod Res. 2012;26(23):2182-7
pubmed: 22236049
Phytomedicine. 2011 Nov 15;18(14):1276-84
pubmed: 21802269
Nature. 1996 Oct 24;383(6602):726-8
pubmed: 8878484
Front Immunol. 2016 Dec 14;7:592
pubmed: 28018358

Auteurs

Luca Gallelli (L)

Department of Health Science, School of Medicine, Operative Unit of Clinical Pharmacology, Mater Domini University Hospital, Catanzaro, Italy.
Research Center FAS@UMG, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Erika Cione (E)

Department of Pharmacy, Health and Nutritional Sciences, Department of Excellence 2018-2022, University of Calabria, Rende, 87036, CS, Italy.

Tian Wang (T)

Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai, People's Republic of China.

Leiming Zhang (L)

Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, School of Pharmacy, Yantai University, Yantai, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH